Concept information
Preferred term
Monoclonal antibody
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Broader concept
Narrower concepts
- Adalimumab (substance)
- Aducanumab (substance)
- Alemtuzumab
- Alirocumab (substance)
- Amivantamab (substance)
- Ansuvimab (substance)
- Arcitumomab (substance)
- Atoltivimab (substance)
- Bebtelovimab
- Belantamab mafodotin
- Belimumab (substance)
- Brentuximab vedotin (substance)
- Canakinumab (substance)
- Casirivimab
- Certolizumab pegol (substance)
- Cetuximab (substance)
- Denosumab (substance)
- Dostarlimab
- Dupilumab
- Emicizumab
- Enfortumab vedotin (substance)
- Eptinezumab (substance)
- Erenumab
- Evinacumab (substance)
- Evolocumab (substance)
- Golimumab
- Imdevimab (substance)
- Inebilizumab
- Infliximab (substance)
- Ipilimumab
- Isatuximab (substance)
- Itolizumab
- Loncastuximab tesirine
- Maftivimab
- Margetuximab (substance)
- Monoclonal immunoglobulin G (substance)
- Naxitamab (substance)
- Ocrelizumab
- Odesivimab (substance)
- Ofatumumab (substance)
- Omalizumab (substance)
- Palivizumab (substance)
- Pertuzumab
- Rituximab (substance)
- Sacituzumab
- Sacituzumab govitecan
- Sarilumab (substance)
- Satralizumab (substance)
- Sotrovimab (substance)
- Tafasitamab (substance)
- Teprotumumab (substance)
- Tocilizumab (substance)
- Trastuzumab deruxtecan
- Trastuzumab emtansine
- Trastuzumab (substance)
- Ustekinumab (substance)
In other languages
-
Persian
URI
http://www.irandoc.acir/onto/irandoc/49616005
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}